The direct antigen-presenting capability of LECs has been demonstrated using in vitro experiments in which LECs pulsed with foreign ova peptide enhanced killing of B16F10-ova tumor cells by ova-specific CD8+ T cells [85]. The gene discussed is CD8A; the disease is neoplasm.